Algo version: 0.98b
PT Kalbe Farma Tbk. is listed at the JKT Exchange
PT Kalbe Farma Tbk. [KLBF.JK]
JKT Sector: Healthcare Industry:Drug Manufacturers—General

Is PT Kalbe Farma Tbk. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PT Kalbe Farma Tbk. pays dividends. Last time was Friday 14th of June 2024 where the investors holding the stock on Wednesday 29th of May 2024 were paid IDR31 per share. Over the last 22 times between 2004 and 2024, PT Kalbe Farma Tbk. has paid IDR550.5 with an average of IDR25.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Kalbe Farma Tbk. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was IDR1 675.00, you would have made a profit of IDR35.00 per share or 2.09%

Yes, the average daily trading liquidity for PT Kalbe Farma Tbk. is IDR30.70 million. You should therefore be able to get in and out of your positions relatively fast.

PT Kalbe Farma Tbk. has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 5.82, the company's ability to pay off the debt is good. PT Kalbe Farma Tbk. has a good net profit margin of 9.27% and should have high tolerances against inflation.

We have calculated the inflation risk for PT Kalbe Farma Tbk. to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.